- Home
- KYMR vs HUBS Comparison
KYMR vs HUBS Comparison
Compare KYMR & HUBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | HUBS |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.5B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KYMR | HUBS |
|---|---|---|
| Price | $104.20 | $249.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 26 | 32 |
| Target Price | $107.72 | ★ $435.19 |
| AVG Volume (30 Days) | 558.9K | ★ 1.3M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 855.56 |
| EPS | N/A | ★ 0.62 |
| Revenue | $39,211,000.00 | ★ $375,612,000.00 |
| Revenue This Year | $10.61 | $20.46 |
| Revenue Next Year | $8.17 | $16.01 |
| P/E Ratio | ★ N/A | $386.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $36.88 | $169.63 |
| 52 Week High | $130.05 | $525.51 |
Technical Indicators
Market Signals| Indicator | KYMR | HUBS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 55.46 |
| Support Level | N/A | $229.01 |
| Resistance Level | N/A | $234.11 |
| Average True Range (ATR) | 0.00 | 14.45 |
| MACD | 0.00 | 1.78 |
| Stochastic Oscillator | 0.00 | 63.43 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
About HUBS HubSpot Inc.
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.